Biopharmaceutical company focused on developing treatments for rare diseases
Biopharmaceutical company focused on developing treatments for rare diseases
Sectors
Healthcare
Life Sciences
First Invested
2015
Early
Company Status
IPO/Acquired
NASDAQ: CMTA
Acquired by Ipsen
Website
Clementia
About
Team
Portfolio
Insights
About
Team
Portfolio
Insights
NEA Portfolio: Clementia